ADLR Adolor Corporation
Adolor Corporation is a development stage biopharmaceutical company, discovers and develops prescription pain management products and has product candidates in development, ranging from preclinical studies to pivotal clinical trials. The Company's product candidate, Entereg (alvimopan), blocks the unwanted effects of opioid analgesics on the gastrointestinal tract. For the global development and commercialization of Entereg as a monotherapy, Adolor is collaborating with Glaxo Group Limited (Glaxo) in multiple indications. The Company is also developing a sterile lidocaine patch, in clinical development, for the treatment of postoperative incisional pain. Additional product candidates, including Delta opioid agonist, are in preclinical development for the treatment of moderate-to-severe pain conditions. In September 2005, Glaxo and Adolor announced the start of Phase III clinical testing to evaluate Entereg for the treatment of opioid-induced bowel dysfunction.
Stock history for ADLR Adolor Corporation
Study Published in Archives of Surgery Demonstrated Benefit of ENTEREG® (alvimopan) in Postoperative Ileus (Business Wire)EXTON, Pa. & PHILADELPHIA----Adolor Corporation and GlaxoSmithKline announced today that the Phase 3 Study 14CL314 of ENTEREG® for the management of postoperative ileus has been published in the November issue of Archives of Surgery, the official publication of the New England Surgical Society, the Pacific Coast Surgical Association and the Western Surgical Association.
Read 
Adolor Corporation to Host Conference Call to Provide R&D Update (Business Wire)EXTON, Pa.----Adolor Corporation today announced that it will hold a conference call at 8:30 a.m. ET on Thursday, December 18, 2008 to provide an R&D program update, including its delta agonist and opioid bowel dysfunction programs.
Read
Adolor Corporation Reports Third Quarter 2008 Financial Results (Business Wire)EXTON, Pa.----Adolor Corporation today reported financial results for the three and nine months ended September 30, 2008.
Read
Adolor Corporation Provides Update on R&D Programs (Business Wire)EXTON, Pa.----Adolor Corporation today provided the following updates related to its research and development programs.
Read
Adolor Corporation Announces Management Appointments (Business Wire)EXTON, Pa.----Adolor Corporation today announced the following promotion and new hires:
Read
ADOLOR CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Change in Directors or Principal Officers (EDGAR Online) Read
ADOLOR CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits (EDGAR Online) Read
Health Winners & Losers: Bristol-Myers (TheStreet.com)The company rides the broader market's wave higher.
Read
Finance news provided by Yahoo! Finance.
